Electroceuticals

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Electroceuticals is a recently coined term that broadly encompasses all bioelectronic medicine that employs electrical stimulation to affect and modify functions of the body.[1] Clinical neural implants such as cochlear implants to restore hearing, retinal implants to restore sight, spinal cord stimulators for pain relief or cardiac pacemakers and implantable defibrillators are conventional examples of electroceuticals. More recent varieties of electroceuticals include the electrical stimulation of the vagus nerve to modulate the immune system in order to provide relief from rheumatoid arthritis and prevent epileptic seizures.[2][3]

History[edit]

The term was coined by British drug giant GlaxoSmithKline.[3]

Advantages[edit]

Some of the advantages of electroceuticals over other conventional means is that they are cheaper and non-invasive.[3]

References[edit]

  1. ^ Famm, Kristoffer; Litt, Brian; Tracey, Kevin J.; Boyden, Edward S.; Slaoui, Moncef (10 April 2013). "Drug discovery: A jump-start for electroceuticals". Nature 496 (7444): 159–161. doi:10.1038/496159a. 
  2. ^ "Vagus Nerve Stimulation for Rheumatoid Arthritis: Interview with Anthony Arnold, CEO of SetPoint Medical". 
  3. ^ a b c Moore, Samuel (29 May 2015). "The Vagus Nerve: A Back Door for Brain Hacking". IEEE Spectrum. Retrieved 4 June 2015. 

Further reading[edit]